Evidence map›Paper›PMID 37171633›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2023

The predictive value of pretherapy [

Azadeh Akhavanallaf, Avery B Peterson, Kellen Fitzpatrick, Molly Roseland, Ka Kit Wong, Issam El-Naqa, Habib Zaidi, Yuni K Dewaraja

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Review
  3. Review
  4. Review
  5. Dual-tracer PET/CT and cocktail therapy with [European journal of nuclear medicine and molecular imaging · 2026
    Article
  6. Dosimetry inJournal of clinical medicine · 2026
    Review
  7. Swin UNETR-based prediction of [BMC medical imaging · 2026
    Article
  8. Article
  9. [EJNMMI physics · 2026
    Article
  10. Review
  11. Review
  12. Quantitative SPECT/CT: Technique and Clinical Applications.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  13. Article
  14. Challenges and Opportunities in Radioligand Therapy.Journal of nuclear medicine technology · 2025
    Review
  15. CanJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  16. Review
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Azadeh AkhavanallafDepartment of Radiology, University of Michigan, 1301 Catherine, 2276 Medical Science I/5610, Ann Arbor, MI, 48109, USA. azadehak@med.umich.edu.ORCID 0000-0002-1486-4702
Avery B PetersonDepartment of Radiology, University of Michigan, 1301 Catherine, 2276 Medical Science I/5610, Ann Arbor, MI, 48109, USA.
Kellen FitzpatrickDepartment of Radiology, University of Michigan, 1301 Catherine, 2276 Medical Science I/5610, Ann Arbor, MI, 48109, USA.
Molly RoselandDepartment of Radiology, University of Michigan, 1301 Catherine, 2276 Medical Science I/5610, Ann Arbor, MI, 48109, USA.
Ka Kit WongDepartment of Radiology, University of Michigan, 1301 Catherine, 2276 Medical Science I/5610, Ann Arbor, MI, 48109, USA.
Issam El-NaqaDepartment of Machine Learning, Moffitt Cancer Center, Tampa, FL, USA.
Habib ZaidiDivision of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211, Geneva, Switzerland.
Yuni K DewarajaDepartment of Radiology, University of Michigan, 1301 Catherine, 2276 Medical Science I/5610, Ann Arbor, MI, 48109, USA.
University of Michigan · USMoffitt Cancer Center · USUniversity Medical Center Groningen · NL

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Scott Michael Schuetze · 1988 to 2026
$178.2M
Bringing Capacity for Theranostic Dosimetry Planning to the Nuclear Medicine ClinicR01CA240706 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DEWARAJA, YUNI K · 2020 to 2024
$3.0M
NCI NIH HHS P30 CA046592NCI NIH HHS P30CA046592NCI NIH HHS R01 CA240706NCI NIH HHS R01CA240706
6 · The paper itself

Abstract

purposeMetastatic neuroendocrine tumors (NETs) overexpressing type 2 somatostatin receptors are the target for peptide receptor radionuclide therapy (PRRT) through the theragnostic pair of

methodsWe retrospectively analyzed 90 segmented metastatic NETs from 25 patients (M14/F11, age 63.7 ± 9.5, range 38-76) treated by

resultsSUV

conclusionOur preliminary results demonstrate the feasibility of using baseline PET images for prediction of absorbed dose prior to

Indexed as

Neuroendocrine TumorsOrganometallic CompoundsAgedBiomarkersGallium RadioisotopesHeterocyclic Compounds, 1-RingHumansMiddle AgedOctreotidePositron-Emission TomographyPositron Emission Tomography Computed TomographyRadionuclide ImagingRetrospective Studies1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidBiomarkerscopper dotatate CU-64Gallium RadioisotopesHeterocyclic Compounds, 1-RingOctreotideOrganometallic Compounds177Lu-DOTATATEDosimetryMachine learningTheragnostic

Identifiers

PMID37171633
PMCPMC10981963
OpenAlexW4376223920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.